CCTA with HeartFlow

Most Accurate Non‑invasive Imaging Test for CAD

Medical Imaging of Fredericksburg (MIF) is advancing the diagnosis of CAD with the HeartFlow Analysis.

The Coronary CT Angiography (CCTA) provides an accurate, detailed view of the coronary arteries, the HeartFlow Analysis provides answers that reduce the need for follow-up testing and evaluation.

The patients’ journey begins with a CCTA. If the physician sees disease, the CCTA images are sent to HeartFlow, where AI algorithms, and trained analysts create the HeartFlow Analysis. This personalized, color-coded 3-D model of a patient’s coronary arteries provides functional information about each blockage.

This pathway provides the highest diagnostic performance available from a non-invasive test to help identify functional disease. This pathway leads to targeted treatment plans and a more streamlined patient experience.

Physicians can use the exam for any clinically stable symptomatic patients.

Within hours, you can receive the
HeartFlow Analysis, which is available on
desktop and mobile device.

Transforming Coronary Artery Disease Detection

  • Most accurate non-invasive imaging test to determine if a patient’s symptoms are caused by CAD.
  • Rapid, safe, highly accurate exam that combines anatomy and function.
  • Improves outcomes, lowers costs by eliminating additional testing, and supports a better patient experience.
  • Leverages advanced technology including artificial intelligence, deep learning, and cloud computing.
  • May prevent invasive catheterization.
  • Covered by all major insurance.

To date, more than 100,000 patients worldwide have received a HeartFlow Analysis.

The momentum is growing with partners in major healthcare systems and local communities bringing HeartFlow to their patients.

For more information:


Coronary Computed Tomography Angiography (CCTA)

Many physicians advocate the careful use of CCTA/Heart Flow for patients who have:

  • Suspected abnormal anatomy of the coronary arteries.
  • Low or intermediate risk for coronary artery disease, including patients who have chest pain and normal, non-diagnostic or unclear lab and ECG results.
  • New or worsening symptoms with a previous normal stress test result.
  • Unclear or inconclusive stress test results.
  • New onset heart failure with reduced heart function and low or medium risk for coronary artery disease.
  • Intermediate risk of coronary artery disease before non-coronary cardiac surgery.
  • Coronary artery bypass grafts.

For patients meeting the above indications, CCTA can provide important information about the presence and extent of plaque in the coronary arteries. Apart from identifying coronary artery narrowing as the cause of chest discomfort, it can also detect other possible causes of symptoms, such as a collapsed lung, blood clot in the vessels leading to the lungs, or aortic abnormalities.

“Medical Imaging of Fredericksburg is proud to now offer HeartFlow Analysis, the latest cardiac imaging test in our fight against coronary artery disease (CAD)”, said Dr. Neil B. Green, Physician Director, Cardiac Imaging, Radiology Associates of Fredericksburg. “Endorsed by the American College of Cardiology (ACC) and the American Heart Association (AHA), HeartFlow is a safe, rapid, highly accurate CT scan, and first line tool, that, in a single 10 second breath hold, provides anatomic and functional information to determine if a patient’s chest pain is caused by CAD.”